What is Citius Oncology, Inc.'s interest income?

Citius Oncology, Inc. (CTOR) reported interest income of $43.72K in Q1 2026.

How has Citius Oncology, Inc.'s interest income changed year-over-year?

Citius Oncology, Inc.'s interest income increased by 380.8% year-over-year, from $9.09K to $43.72K.

What does interest income mean?

Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Citius Oncology, Inc. CTOR Interest Income

Interest Income at other companies

Iovance Biotherapeutics, Inc.IOVA

$1.33M-58.6%

Cullinan Therapeutics, Inc.CGEM

$4.1M-37.7%

Nektar TherapeuticsNKTR

$4.24M+47.6%

United TherapeuticsUTHR

$41.8M-18.2%

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s interest income?: Citius Oncology, Inc. (CTOR) reported interest income of $43.72K in Q1 2026.
How has Citius Oncology, Inc.'s interest income changed year-over-year?: Citius Oncology, Inc.'s interest income increased by 380.8% year-over-year, from $9.09K to $43.72K.
What does interest income mean?: Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.